Stock GPCR STRUCTURE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Structure Therapeutics Inc.

Equities

GPCR

US86366E1064

Market Closed - Nasdaq
Other stock markets
 01:30:00 18/05/2024 am IST 		5-day change 1st Jan Change
36.15 USD +0.75% Intraday chart for Structure Therapeutics Inc. +0.92% -11.31%
09/05 Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
09/04 Cantor Fitzgerald Initiates Structure Therapeutics at Overweight Rating With $65 Price Target MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Initiates Structure Therapeutics at Overweight Rating With $65 Price Target
MT
JMP Securities Adjusts Structure Therapeutics' Price Target to $91 From $90, Keeps Market Outperform Rating
MT
Piper Sandler Raises Price Target on Structure Therapeutics to $93 From $58, Maintains Overweight Rating
MT
JMP Securities Starts Coverage on Structure Therapeutics with Market Outperform Rating, $90 Price Target
MT
BMO Capital Adjusts Structure Therapeutics Price Target to $83 From $40, Maintains Outperform Rating
MT
Piper Sandler Initiates Structure Therapeutics With Overweight Rating, $58 Price Target
MT
SVB Securities Initiates Structure Therapeutics at Outperform Rating With $33 Price Target
MT
BMO Capital Initiates Structure Therapeutics at Outperform With $40 Price Target
MT
Jefferies Initiates Structure Therapeutics at Buy With $34 Price Target
MT
Guggenheim Starts Structure Therapeutics at Buy With $50 Price Target
MT
Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GPCR Stock
  4. News Structure Therapeutics Inc.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW